Talphera Stock Performance

TLPH Stock   0.64  0.02  3.23%   
The entity has a beta of 1.35, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Talphera will likely underperform. At this point, Talphera has a negative expected return of -0.32%. Please make sure to validate Talphera's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Talphera performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talphera has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Last Split Factor
1:20
Last Split Date
2022-10-26
1
Insider Trading
10/01/2024
2
Disposition of 1623 shares by Vincent Angotti of Talphera at 1.3 subject to Rule 16b-3
10/25/2024
3
Talphera Upgraded by Maxim Group to Strong-Buy Rating
11/12/2024
4
AcelRx Pharmaceuticals GAAP EPS of -0.13 beats by 0.07
11/13/2024
5
Talphera, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
6
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.7299 subject to Rule 16b-3
11/27/2024
7
Talphera CEO Vincent J. Angotti buys 3,649 in company stock
12/02/2024
8
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.6399 subject to Rule 16b-3
12/05/2024
Begin Period Cash Flow20.3 M
  

Talphera Relative Risk vs. Return Landscape

If you would invest  91.00  in Talphera on September 22, 2024 and sell it today you would lose (27.00) from holding Talphera or give up 29.67% of portfolio value over 90 days. Talphera is currently does not generate positive expected returns and assumes 7.088% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than Talphera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Talphera is expected to under-perform the market. In addition to that, the company is 8.81 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.04 per unit of volatility.

Talphera Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Talphera's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Talphera, and traders can use it to determine the average amount a Talphera's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0445

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTLPH

Estimated Market Risk

 7.09
  actual daily
63
63% of assets are less volatile

Expected Return

 -0.32
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Talphera is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Talphera by adding Talphera to a well-diversified portfolio.

Talphera Fundamentals Growth

Talphera Stock prices reflect investors' perceptions of the future prospects and financial health of Talphera, and Talphera fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Talphera Stock performance.

About Talphera Performance

By evaluating Talphera's fundamental ratios, stakeholders can gain valuable insights into Talphera's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Talphera has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Talphera has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 149.35  156.82 
Return On Tangible Assets(1.59)(1.51)
Return On Capital Employed(1.06)(1.12)
Return On Assets(0.90)(0.95)
Return On Equity(1.30)(1.24)

Things to note about Talphera performance evaluation

Checking the ongoing alerts about Talphera for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Talphera help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Talphera generated a negative expected return over the last 90 days
Talphera has high historical volatility and very poor performance
Talphera has some characteristics of a very speculative penny stock
Talphera has a very high chance of going through financial distress in the upcoming years
Talphera was previously known as AcelRx Pharmaceuticals and was traded on NASDAQ Exchange under the symbol ACRX.
Talphera currently holds 6.29 M in liabilities with Debt to Equity (D/E) ratio of 0.17, which may suggest the company is not taking enough advantage from borrowing. Talphera has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Talphera's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 651 K. Net Loss for the year was (18.4 M) with profit before overhead, payroll, taxes, and interest of 0.
Talphera currently holds about 90.29 K in cash with (17.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Talphera has a poor financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.6399 subject to Rule 16b-3
Evaluating Talphera's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Talphera's stock performance include:
  • Analyzing Talphera's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Talphera's stock is overvalued or undervalued compared to its peers.
  • Examining Talphera's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Talphera's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Talphera's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Talphera's stock. These opinions can provide insight into Talphera's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Talphera's stock performance is not an exact science, and many factors can impact Talphera's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Talphera Stock analysis

When running Talphera's price analysis, check to measure Talphera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talphera is operating at the current time. Most of Talphera's value examination focuses on studying past and present price action to predict the probability of Talphera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talphera's price. Additionally, you may evaluate how the addition of Talphera to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets